Volume 61, Issue 4, Pages (April 2002)

Slides:



Advertisements
Similar presentations
Volume 68, Pages S24-S28 (July 2005)
Advertisements

M. Mizobuchi, J.L. Finch, D.R. Martin, E. Slatopolsky 
Volume 79, Pages S3-S8 (April 2011)
RenaGel®, a nonabsorbed calcium- and aluminum-free phosphate binder, lowers serum phosphorus and parathyroid hormone  Eduardo A. Slatopolsky, Steven K.
Selenium-deficient diet induces renal oxidative stress and injury via TGF-β1 in normal and diabetic rats  Alluru S. Reddi, Jaya S. Bollineni  Kidney International 
E. Cavalier, P. Delanaye, A. Carlisi, J. -M. Krzesinski, J. -P
Volume 60, Issue 6, Pages (December 2001)
Volume 67, Pages S1-S7 (June 2005)
Volume 64, Issue 3, Pages (September 2003)
Volume 55, Issue 3, Pages (March 1999)
FGF23 or PTH: which comes first in CKD ?
Vitamin D deficiency and heart disease
RenaGel®, a nonabsorbed calcium- and aluminum-free phosphate binder, lowers serum phosphorus and parathyroid hormone  Eduardo A. Slatopolsky, Steven K.
Volume 67, Issue 2, Pages (February 2005)
Adenovirus-mediated kallikrein gene delivery reverses salt-induced renal injury in Dahl salt-sensitive rats  Julie Chao, Jenny J. Zhang, Kuei-Fu Lin,
Volume 79, Pages S3-S8 (April 2011)
Volume 70, Issue 3, Pages (August 2006)
M. Fukagawa, S. Nakanishi, J.J. Kazama  Kidney International 
Differential effects of 19-nor-1,25-(OH)2D2 and 1α-hydroxyvitamin D2 on calcium and phosphorus in normal and uremic rats  Eduardo Slatopolsky, Mario Cozzolino,
Chapter 3: Management of progression and complications of CKD
Effect of acidosis on urine supersaturation and stone formation in genetic hypercalciuric stone-forming rats  David A. Bushinsky, Marc D. Grynpas, John.
Volume 60, Issue 6, Pages (December 2001)
Volume 60, Issue 4, Pages (October 2001)
Volume 76, Pages S50-S99 (August 2009)
Volume 64, Issue 2, Pages (August 2003)
Volume 70, Pages S12-S15 (July 2006)
Effects of antihypertensive therapy on intrarenal angiotensin and bradykinin levels in experimental renal insufficiency  Fiona E. Mackie, Timothy W. Meyer,
Volume 60, Issue 5, Pages (November 2001)
Graphic Interpretation of Serum Parathyroid Hormone, Calcium, and Phosphorus Values in Primary Hyperparathyroidism  Pai C. Kao, Ph.D., Edward G. Lufkin,
The need for reliable serum parathyroid hormone measurements
New vitamin D analogs Kidney International
Volume 87, Issue 2, Pages (February 2015)
Volume 67, Pages S33-S36 (June 2005)
Correction to "Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate.
Volume 54, Issue 3, Pages (September 1998)
Ewa Lewin, Yolanda Almaden, Mariano Rodriguez, Klaus Olgaard 
The calcium–phosphorus in guidelines for CKD-MBD
Volume 69, Issue 3, Pages (February 2006)
Head-to-head comparison of the new calcimimetic agent evocalcet with cinacalcet in Japanese hemodialysis patients with secondary hyperparathyroidism 
Volume 68, Pages S24-S28 (July 2005)
M. Mizobuchi, J.L. Finch, D.R. Martin, E. Slatopolsky 
Volume 69, Issue 12, Pages (June 2006)
Volume 69, Issue 3, Pages (February 2006)
Volume 55, Issue 4, Pages (April 1999)
Volume 87, Issue 3, Pages (March 2015)
Volume 59, Issue 3, Pages (March 2001)
Kaihui Liang, Nosratola D. Vaziri  Kidney International 
Neurogenic factors and hypertension in renal disease
Nicotinamide suppresses hyperphosphatemia in hemodialysis patients
Treatment with pyrophosphate inhibits uremic vascular calcification
Volume 57, Issue 4, Pages (April 2000)
Volume 53, Issue 5, Pages (May 1998)
Volume 56, Issue 3, Pages (September 1999)
Volume 58, Issue 3, Pages (September 2000)
Volume 62, Issue 3, Pages (September 2002)
Increased parathyroid expression of klotho in uremic rats
Volume 66, Issue 6, Pages (December 2004)
Volume 64, Issue 1, Pages (July 2003)
Recent developments in the management of secondary hyperparathyroidism
Chronic metabolic acidosis in azotemic rats on a high-phosphate diet halts the progression of renal disease  Aquiles Jara, Arnold J. Felsenfeld, Jordi.
Cheryl P. Sanchez, Yu-Zhu He, Ellen Leiferman, Norman J. Wilsman 
Volume 61, Issue 1, Pages (January 2002)
Increased fetuin-A levels following treatment with a vitamin D analog
Volume 60, Issue 5, Pages (November 2001)
Control of uremic bone disease: Role of vitamin D analogs
Volume 55, Issue 4, Pages (April 1999)
Volume 87, Issue 6, Pages (June 2015)
Volume 55, Issue 5, Pages (May 1999)
A novel mechanism for skeletal resistance in uremia
Volume 64, Pages S131-S136 (November 2003)
Presentation transcript:

Volume 61, Issue 4, Pages 1332-1338 (April 2002) Hyperplasia of the parathyroid gland without secondary hyperparathyroidism  Fumiaki Takahashi, Masashi Denda, Jane L. Finch, Alex J. Brown, Eduardo Slatopolsky  Kidney International  Volume 61, Issue 4, Pages 1332-1338 (April 2002) DOI: 10.1046/j.1523-1755.2002.00265.x Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 1 (A) Effects of two weeks of high dietary phosphorus (HP) or two weeks of high dietary phosphorus followed by one week of low dietary phosphorus (LP) on serum parathyroid hormone (PTH) in uremic (U) rats. Results from normal rats (N) fed the high phosphorus for 2 weeks are shown for comparison. N = 10 for the N-HP group, N = 6 for the U-HP group and N = 5 for the U-HP-LP group. *P < 0.001 vs. N-HP and **P < 0.01 vs. U-HP. (B) The corresponding parathyroid gland weights for the rats shown in panel A. *P < 0.001 vs. N-HP. Results are expressed as mean ± SEM. Kidney International 2002 61, 1332-1338DOI: (10.1046/j.1523-1755.2002.00265.x) Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 2 Correlation analysis of between serum intact PTH and serum phosphorus levels in the two groups of uremic rats (r= 0.948;P< 0.0001). Symbols are: (•) uremic rats fed the high-phosphorus diet for two weeks (U-HP); (▴) uremic rats fed the high-phosphorus diet for two weeks followed by the low-phosphorus diet for one week (U-HP-LP). N = 6 for the U-HP group and N = 5 for the U-HP-LP group. Kidney International 2002 61, 1332-1338DOI: (10.1046/j.1523-1755.2002.00265.x) Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 3 (A) Effects of two weeks of high dietary phosphorus or two weeks of high dietary phosphorus followed by one week of low dietary phosphorus on cytosolic parathyroid gland PTH in uremic rats. Results from normal rats fed the high phosphorus for 2 weeks are shown for comparison. N = 10 for the N-HP group, N = 6 for the U-HP group and N = 5 for the U-HP-LP group. *P < 0.01 vs. N-HP. (B) This graph shows the same results corrected by DNA content. *P < 0.01 vs. N-HP. Results are expressed as mean ± SEM. Kidney International 2002 61, 1332-1338DOI: (10.1046/j.1523-1755.2002.00265.x) Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 4 Correlation analysis of between PTG weight and PTG-PTH content in all three groups of rats. Symbols are: (○) normal rats fed the high-phosphorus diet for 2 weeks (N-HP); (•) uremic rats fed the high-phosphorus diet for 2 weeks (U-HP); (▴) uremic rats fed the high-phosphorus diet for 2 weeks followed by the low-phosphorus diet for 1 week (U-HP-LP). N = 10 for the N-HP group, N = 6 for the U-HP group and N = 5 for the U-HP-LP group; r = 0.889; P < 0.0001. Kidney International 2002 61, 1332-1338DOI: (10.1046/j.1523-1755.2002.00265.x) Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 5 (A) Effects of an IP injection of 200 mg/kg of EDTA on serum ionized calcium in uremic rats fed a high P diet for 2 weeks or a high P diet for 2 weeks followed by one week of a low P diet. Results from normal rats fed the high P for 2 weeks are shown for comparison. Symbols are: (▪) values prior to the EDTA injection; () values obtained 30 minutes after the EDTA injection. N = 7 for the N-HP group, N = 5 for the U-HP group and N = 6 for the U-HP-LP group. (B) Effects of an IP injection of 200 mg/kg of EDTA on serum intact PTH in the same rats shown in panel A. *P < 0.01 vs. pre-values. Results are expressed as mean ± SEM. Kidney International 2002 61, 1332-1338DOI: (10.1046/j.1523-1755.2002.00265.x) Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 6 (A) Effects of 2 weeks of high dietary P or 2 weeks of high dietary P followed by one week of low dietary P on the PTH/β-actin mRNA levels in parathyroid glands from uremic rats. Results from normal rats fed the high P for 2 weeks are shown for comparison. N = 5 for the N-HP group, N = 5 for the U-HP group and N = 4 for the U-HP-LP group. (B) Effects of 2 weeks of high dietary P or 2 weeks of high dietary P followed by one week of low dietary P on 35S incorporation in newly synthesized PTH in parathyroid glands from uremic rats. Results from normal rats fed the high P for 2 weeks are shown for comparison. N = 5 for the U-HP group and N = 5 for the U-HP-LP group. Results are expressed as mean ± SEM. Kidney International 2002 61, 1332-1338DOI: (10.1046/j.1523-1755.2002.00265.x) Copyright © 2002 International Society of Nephrology Terms and Conditions